Next-generation sequencing in oncology: genetic diagnosis, risk prediction and cancer classification
R Kamps, RD Brandão, BJ van den Bosch… - International journal of …, 2017 - mdpi.com
Next-generation sequencing (NGS) technology has expanded in the last decades with
significant improvements in the reliability, sequencing chemistry, pipeline analyses, data …
significant improvements in the reliability, sequencing chemistry, pipeline analyses, data …
Next-generation sequencing: advances and applications in cancer diagnosis
S Serratì, S De Summa, B Pilato, D Petriella… - OncoTargets and …, 2016 - Taylor & Francis
Technological advances have led to the introduction of next-generation sequencing (NGS)
platforms in cancer investigation. NGS allows massive parallel sequencing that affords …
platforms in cancer investigation. NGS allows massive parallel sequencing that affords …
Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: guideline from the College of …
NI Lindeman, PT Cagle, DL Aisner… - … of pathology & …, 2018 - meridian.allenpress.com
Context.—In 2013, an evidence-based guideline was published by the College of American
Pathologists, the International Association for the Study of Lung Cancer, and the Association …
Pathologists, the International Association for the Study of Lung Cancer, and the Association …
Targeted next‐generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas
Intraductal neoplasms are important precursors to invasive pancreatic cancer and provide
an opportunity to detect and treat pancreatic neoplasia before an invasive carcinoma …
an opportunity to detect and treat pancreatic neoplasia before an invasive carcinoma …
[HTML][HTML] Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups
One-hundred-fifty-three biliary cancers, including 70 intrahepatic cholangiocarcinomas
(ICC), 57 extrahepatic cholangiocarcinomas (ECC) and 26 gallbladder carcinomas (GBC) …
(ICC), 57 extrahepatic cholangiocarcinomas (ECC) and 26 gallbladder carcinomas (GBC) …
MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer
Lung cancer is the leading cause of cancer-related deaths worldwide. Despite
advancements and improvements in surgical and medical treatments, the survival rate of …
advancements and improvements in surgical and medical treatments, the survival rate of …
Preanalytic variables in cytology: lessons learned from next-generation sequencing—the MD Anderson experience
S Roy-Chowdhuri, J Stewart - Archives of pathology & …, 2016 - meridian.allenpress.com
Context.—As our understanding of genomic alterations underlying solid tumor malignancies
continues to evolve, molecular testing of tumor samples is increasingly used to guide …
continues to evolve, molecular testing of tumor samples is increasingly used to guide …
Expert opinion on NSCLC small specimen biomarker testing—Part 2: Analysis, reporting, and quality assessment
F Penault-Llorca, KM Kerr, P Garrido, E Thunnissen… - Virchows Archiv, 2022 - Springer
The diagnostic work-up for non-small cell lung cancer (NSCLC) requires biomarker testing
to guide therapy choices. This article is the second of a two-part series. In Part 1, we …
to guide therapy choices. This article is the second of a two-part series. In Part 1, we …
Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract: targeted next-generation sequencing suggests a monoclonal origin of the two components
M Scardoni, E Vittoria, M Volante, B Rusev… - …, 2015 - karger.com
Background: Mixed adenoneuroendocrine carcinomas (MANECs) of the gastrointestinal
tract are rare neoplasms characterized by coexisting exocrine and neuroendocrine …
tract are rare neoplasms characterized by coexisting exocrine and neuroendocrine …
Biomarker testing in lung carcinoma cytology specimens: a perspective from members of the Pulmonary Pathology Society
S Roy-Chowdhuri, DL Aisner… - … of pathology & …, 2016 - meridian.allenpress.com
The advent of targeted therapy in lung cancer has heralded a paradigm shift in the practice
of cytopathology with the need for accurately subtyping lung carcinoma, as well as providing …
of cytopathology with the need for accurately subtyping lung carcinoma, as well as providing …